INTERNATIONAL PATENT: SITEONE THERAPEUTICS, INC. FILES APPLICATION FOR "SUBSTITUTED CYCLOALKYL AND HETEROCYCLOALKYL INHIBITORS OF NAV1.8 FOR THE TREATMENT OF PAIN"

GENEVA, Nov. 25 -- SITEONE THERAPEUTICS, INC. (951-3 Gateway BoulevardSouth San Francisco, CA 94080) filed a patent application (PCT/US2025/029820) for "SUBSTITUTED CYCLOALKYL AND HETEROCYCLOALKYL INHIBITORS OF NAv1.8 FOR THE TREATMENT OF PAIN" on May 16, 2025. With publication no. WO/2025/240895, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MULCAHY, John (c/o Siteone Therapeutics, Inc.951-3 Gateway BoulevardSouth San Francisco, CA 94080), ZHU, Jie (c/o Siteone Therapeutics, Inc.951-3 Gateway BoulevardSouth San Francis...